This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (571) Attention Deficit Disorder (ADD/ADHD) (60) Mental Health Issues in Adolescence (442) Chronic Disease Self-Management in Childhood and Adolescence (139) Developmental Problems (47) Pharmacology and Pharmaceutics (66) Drug Repurposing and Off-Label Use (25)

Published on in Vol 10, No 10 (2021): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/31281, first published .
Pharmacokinetics and Perceptions of Children and Young Adults Using Cannabis for Attention-Deficit/Hyperactivity Disorder and Oppositional Defiant Disorder: Protocol for a Mixed Methods Proof-of-Concept Study

Pharmacokinetics and Perceptions of Children and Young Adults Using Cannabis for Attention-Deficit/Hyperactivity Disorder and Oppositional Defiant Disorder: Protocol for a Mixed Methods Proof-of-Concept Study

Pharmacokinetics and Perceptions of Children and Young Adults Using Cannabis for Attention-Deficit/Hyperactivity Disorder and Oppositional Defiant Disorder: Protocol for a Mixed Methods Proof-of-Concept Study

Authors of this article:

Holly Mansell1 Author Orcid Image ;   Declan Quinn2 Author Orcid Image ;   Lauren E Kelly3 Author Orcid Image ;   Michael Szafron4 Author Orcid Image ;   Jane Alcorn1 Author Orcid Image
Article Authors Cited by (7) Tweetations Metrics

Journals

  1. Qian Y, Markowitz J. Prediction of Carboxylesterase 1-mediated In Vivo Drug Interaction between Methylphenidate and Cannabinoids using Static and Physiologically Based Pharmacokinetic Models. Drug Metabolism and Disposition 2022;50(7):968 View
  2. Efron D, Taylor K. Medicinal Cannabis for Paediatric Developmental, Behavioural and Mental Health Disorders. International Journal of Environmental Research and Public Health 2023;20(8):5430 View
  3. De Gier C, Scharinger C, Stark R, Steurer P, Klier C. Tetrahydrocannabinol in Pediatrics: Room for Improvement?. Medical Cannabis and Cannabinoids 2023;6(1):125 View
  4. Kelly L, Rieder M, Finkelstein Y. Medical cannabis for children: Evidence and recommendations. Paediatrics & Child Health 2024;29(2):104 View
  5. Kelly L, Rieder M, Finkelstein Y. Les données probantes et les recommandations sur le cannabis à des fins médicales chez les enfants. Paediatrics & Child Health 2024;29(2):113 View
  6. Ikeda P, Campagnaro E, Natali G, Torres C. Consequências do uso de cannabis em pacientes com Transtorno de Atenção e Hiperatividade. Caderno Pedagógico 2024;21(9):e7642 View
  7. Lemos Amorim V, Alexandre Bezerra Júnior C, Ribeiro Bubula L, Custódio Martinez Sacchi P. IMPACTOS DO USO DE CANNABIS EM INDIVÍDUOS COM TDAH: EFEITOS COGNITIVOS, DECISÕES E POSSÍVEIS BENEFÍCIOS TERAPÊUTICOS. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218 2024;5(10):e5105768 View